1. Lymphoma of bone, also known as primary reticulum cell sarcoma or histiocytic lymphoma, is a rare form of non-Hodgkin's lymphoma that affects the bone.
2. It represents around 5% of primary bone tumors and less than 1% of non-Hodgkin's lymphomas. It most commonly affects the lower femur, upper tibia, and humerus.
3. Symptoms include chronic dull pain and a striking contrast between the size of the bone lesion and the patient's overall well-being. The 5-year survival rate is approximately 54%.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
1. Lymphoma of bone, also known as primary reticulum cell sarcoma or histiocytic lymphoma, is a rare form of non-Hodgkin's lymphoma that affects the bone.
2. It represents around 5% of primary bone tumors and less than 1% of non-Hodgkin's lymphomas. It most commonly affects the lower femur, upper tibia, and humerus.
3. Symptoms include chronic dull pain and a striking contrast between the size of the bone lesion and the patient's overall well-being. The 5-year survival rate is approximately 54%.
1. Lymphoma of bone, also known as primary reticulum cell sarcoma or histiocytic lymphoma, is a rare form of non-Hodgkin's lymphoma that affects the bone.
2. It represents around 5% of primary bone tumors and less than 1% of non-Hodgkin's lymphomas. It most commonly affects the lower femur, upper tibia, and humerus.
3. Symptoms include chronic dull pain and a striking contrast between the size of the bone lesion and the patient's overall well-being. The 5-year survival rate is approximately 54%.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
1. Lymphoma of bone, also known as primary reticulum cell sarcoma or histiocytic lymphoma, is a rare form of non-Hodgkin's lymphoma that affects the bone.
2. It represents around 5% of primary bone tumors and less than 1% of non-Hodgkin's lymphomas. It most commonly affects the lower femur, upper tibia, and humerus.
3. Symptoms include chronic dull pain and a striking contrast between the size of the bone lesion and the patient's overall well-being. The 5-year survival rate is approximately 54%.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Download as doc, pdf, or txt
You are on page 1of 1
Lymphoma of Bone
• = RETICULUM CELL SARCOMA = HISTIOCYTIC LYMPHOMA
= PRIMARY LYMPHOMA OF BONE • = singular bone lesion • the generalized form of reticulum cell sarcoma is lymphoma Prevalence 5% of all primary bone tumors; <1% of all NHL; 2–6% of all : primary malignant bone tumors in children • Incidence of bone marrow involvement: o 5–15% in Hodgkin disease; o 25–40% in non-Hodgkin lymphoma o Bone marrow involvement indicates progression of disease o Bone marrow imaging-guidance for biopsy! NUC: 40% sensitivity; 88% specificity MR: 65% sensitivity; 90% specificity Histo mostly large B-cell category; sheets of reticulum cells, larger than those : in Ewing sarcoma (DDx: myeloma, inflammation, osteosarcoma, eosinophilic granuloma) Age: bimodal distribution with peaks in 2nd–3rd and 5th–6th decades; 50% <40 years; 35% <30 years; M:F = 2:1 • • chronic dull pain • • striking contrast between size of lesion + patient's well-being Location lower femur, upper tibia (40% about knee), humerus, pelvis, scapula, : ribs, vertebra Site: dia- / metaphysis • cancellous bone erosion (earliest sign) • mottled permeative pattern of separate coalescent areas • late cortical destruction • lamellated / sunburst periosteal response (rare and less than in Ewing sarcoma) • lytic / reactive new-bone formation • associated soft-tissue mass without calcification (70%) • synovitis of knee joint common
Cx: pathologic fracture (most common among malignant bone tumors)